- Home
- QURE vs SABR Comparison
QURE vs SABR Comparison
Compare QURE & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | SABR |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Netherlands | United States |
| Employees | 248 | 4650 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.4M | 652.0M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | QURE | SABR |
|---|---|---|
| Price | $17.69 | $1.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $45.42 | $3.70 |
| AVG Volume (30 Days) | 4.5M | ★ 17.3M |
| Earning Date | 06-02-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.67 | ★ 283.56 |
| EPS | N/A | ★ 1.34 |
| Revenue | $13,107,000.00 | ★ $3,866,956,000.00 |
| Revenue This Year | $126.14 | $7.40 |
| Revenue Next Year | $395.00 | $3.26 |
| P/E Ratio | ★ N/A | $1.24 |
| Revenue Growth | N/A | ★ 7.46 |
| 52 Week Low | $7.76 | $0.81 |
| 52 Week High | $71.50 | $3.63 |
Technical Indicators
Market Signals| Indicator | QURE | SABR |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 60.31 |
| Support Level | $13.29 | $1.63 |
| Resistance Level | $26.84 | $1.70 |
| Average True Range (ATR) | 2.09 | 0.20 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 52.73 | 71.01 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.